Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Go back to Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors| (NASDAQ: LEGN) | Delayed: 20.63 -0.89 (4.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.52 | 52 Week High | $ | |||
| Open | $21.63 | 52 Week Low | $ | |||
| Day High | $21.97 | P/E | N/A | |||
| Day Low | $20.54 | EPS | $ | |||
| Volume | 1,152,154 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.82 -0.48 (3.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.30 | 52 Week High | $117.12 | |||
| Open | $15.10 | 52 Week Low | $46.52 | |||
| Day High | $15.25 | P/E | N/A | |||
| Day Low | $14.63 | EPS | $-1.97 | |||
| Volume | 3,794,667 | |||||
